Total knee arthroplasty: analysis shows EXPAREL reduces length of hospital stay and improves discharge status compared to standard analgesic modality

Pacira Pharmaceuticals, Inc. has announced results of new data showing that EXPAREL® (bupivacaine liposome injectable suspension) infiltration compared to a standard analgesic regimen in patients undergoing total knee arthroplasty (TKA) significantly decreased the length of hospital stay and increased the likelihood that a patient would be discharged to their home rather than a care facility when released from the hospital.

Source: Medical News Today

Read More

Dr. Paul Jacob
Oklahoma Joint
Reconstruction Institute

9800 Broadway Ext.
Suite 201
Oklahoma City, OK 73114

Dr. Gerardo Myrin
Oklahoma Joint
Reconstruction Institute

3115 SW 89th Street
Oklahoma City,
OK 73159